Data Year:

For its 2024 fiscal year, MEDICAL PROPERTIES TRUST, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In Financial Services industry
Edward K. Aldag Jr.
Chairman, President, and Chief Executive Officer
Total Compensation $16,388,255 View details Pay Rank By Title In Financial Services industry #52 View more
R. Steven Hamner
Director, Executive Vice President and Chief Financial Officer
Total Compensation $8,406,514 View details Pay Rank By Title In Financial Services industry #24 View more
Rosa H. Hooper
Senior Vice President, Operations and Secretary
Total Compensation $797,699 View details Pay Rank By Title In Financial Services industry #91 View more
J. Kevin Hanna
Senior Vice President, Controller and Chief Accounting Officer
Total Compensation $1,153,834 View details Pay Rank By Title In Financial Services industry #61 View more
Larry H. Portal
Senior Vice President, Senior Advisor to the CEO
Total Compensation $1,663,295 View details Pay Rank By Title In Financial Services industry #7 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at MEDICAL PROPERTIES TRUST as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. MEDICAL PROPERTIES TRUST income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. MEDICAL PROPERTIES TRUST annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Edward K. Aldag Jr.
Chairman, President, and Chief Executive Officer
Total Cash $3,556,599 Equity $12,689,910 Other $141,746 $16,388,255
R. Steven Hamner
Director, Executive Vice President and Chief Financial Officer
Total Cash $2,010,352 Equity $6,344,955 Other $51,207 $8,406,514
Rosa H. Hooper
Senior Vice President, Operations and Secretary
Total Cash $778,995 Equity $0 Other $18,704 $797,699
J. Kevin Hanna
Senior Vice President, Controller and Chief Accounting Officer
Total Cash $1,115,000 Equity $0 Other $38,834 $1,153,834
Larry H. Portal
Senior Vice President, Senior Advisor to the CEO
Total Cash $1,643,750 Equity $0 Other $19,545 $1,663,295
For its 2024 fiscal year, MEDICAL PROPERTIES TRUST, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Edward K. Aldag Jr. CEO Pay $16,388,255 Median Employee Pay $155,204 CEO Pay Ratio 106:1
For its 2024 fiscal year, MEDICAL PROPERTIES TRUST, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
C. Reynolds Thompson, III Total Cash $273,032
Caterina A. Mozingo Total Cash $273,032
D. Paul Sparks, Jr. Total Cash $243,032
Elizabeth N. Pitman Total Cash $303,032
Emily W. Murphy Total Cash $243,032
G. Steven Dawson Total Cash $278,032
Michael G. Stewart Total Cash $293,032
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.